Cargando…

Multiple uncontrolled conditions and blood pressure medication intensification: an observational study

BACKGROUND: Multiple uncontrolled medical conditions may act as competing demands for clinical decision making. We hypothesized that multiple uncontrolled cardiovascular risk factors would decrease blood pressure (BP) medication intensification among uncontrolled hypertensive patients. METHODS: We o...

Descripción completa

Detalles Bibliográficos
Autores principales: Salanitro, Amanda H, Funkhouser, Ellen, Agee, Bonita S, Allison, Jeroan J, Halanych, Jewell H, Houston, Thomas K, Litaker, Mark S, Levine, Deborah A, Safford, Monika M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914084/
https://www.ncbi.nlm.nih.gov/pubmed/20642844
http://dx.doi.org/10.1186/1748-5908-5-55
_version_ 1782184741803393024
author Salanitro, Amanda H
Funkhouser, Ellen
Agee, Bonita S
Allison, Jeroan J
Halanych, Jewell H
Houston, Thomas K
Litaker, Mark S
Levine, Deborah A
Safford, Monika M
author_facet Salanitro, Amanda H
Funkhouser, Ellen
Agee, Bonita S
Allison, Jeroan J
Halanych, Jewell H
Houston, Thomas K
Litaker, Mark S
Levine, Deborah A
Safford, Monika M
author_sort Salanitro, Amanda H
collection PubMed
description BACKGROUND: Multiple uncontrolled medical conditions may act as competing demands for clinical decision making. We hypothesized that multiple uncontrolled cardiovascular risk factors would decrease blood pressure (BP) medication intensification among uncontrolled hypertensive patients. METHODS: We observed 946 encounters at two VA primary care clinics from May through August 2006. After each encounter, clinicians recorded BP medication intensification (BP medication was added or titrated). Demographic, clinical, and laboratory information were collected from the medical record. We examined BP medication intensification by presence and control of diabetes and/or hyperlipidemia. 'Uncontrolled' was defined as hemoglobin A1c ≥ for diabetes, BP ≥ 140/90 mmHg (≥ 130/80 mmHg if diabetes present) for hypertension, and low density lipoprotein cholesterol (LDL-c) ≥ 130 mg/dl (≥ 100 mg/dl if diabetes present) for hyperlipidemia. Hierarchical regression models accounted for patient clustering and adjusted medication intensification for age, systolic BP, and number of medications. RESULTS: Among 387 patients with uncontrolled hypertension, 51.4% had diabetes (25.3% were uncontrolled) and 73.4% had hyperlipidemia (22.7% were uncontrolled). The BP medication intensification rate was 34.9% overall, but higher in individuals with uncontrolled diabetes and uncontrolled hyperlipidemia: 52.8% overall and 70.6% if systolic BP ≥ 10 mmHg above goal. Intensification rates were lowest if diabetes or hyperlipidemia were controlled, lower than if diabetes or hyperlipidemia were not present. Multivariable adjustment yielded similar results. CONCLUSIONS: The presence of uncontrolled diabetes and hyperlipidemia was associated with more guideline-concordant hypertension care, particularly if BP was far from goal. Efforts to understand and improve BP medication intensification in patients with controlled diabetes and/or hyperlipidemia are warranted.
format Text
id pubmed-2914084
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29140842010-08-03 Multiple uncontrolled conditions and blood pressure medication intensification: an observational study Salanitro, Amanda H Funkhouser, Ellen Agee, Bonita S Allison, Jeroan J Halanych, Jewell H Houston, Thomas K Litaker, Mark S Levine, Deborah A Safford, Monika M Implement Sci Research Article BACKGROUND: Multiple uncontrolled medical conditions may act as competing demands for clinical decision making. We hypothesized that multiple uncontrolled cardiovascular risk factors would decrease blood pressure (BP) medication intensification among uncontrolled hypertensive patients. METHODS: We observed 946 encounters at two VA primary care clinics from May through August 2006. After each encounter, clinicians recorded BP medication intensification (BP medication was added or titrated). Demographic, clinical, and laboratory information were collected from the medical record. We examined BP medication intensification by presence and control of diabetes and/or hyperlipidemia. 'Uncontrolled' was defined as hemoglobin A1c ≥ for diabetes, BP ≥ 140/90 mmHg (≥ 130/80 mmHg if diabetes present) for hypertension, and low density lipoprotein cholesterol (LDL-c) ≥ 130 mg/dl (≥ 100 mg/dl if diabetes present) for hyperlipidemia. Hierarchical regression models accounted for patient clustering and adjusted medication intensification for age, systolic BP, and number of medications. RESULTS: Among 387 patients with uncontrolled hypertension, 51.4% had diabetes (25.3% were uncontrolled) and 73.4% had hyperlipidemia (22.7% were uncontrolled). The BP medication intensification rate was 34.9% overall, but higher in individuals with uncontrolled diabetes and uncontrolled hyperlipidemia: 52.8% overall and 70.6% if systolic BP ≥ 10 mmHg above goal. Intensification rates were lowest if diabetes or hyperlipidemia were controlled, lower than if diabetes or hyperlipidemia were not present. Multivariable adjustment yielded similar results. CONCLUSIONS: The presence of uncontrolled diabetes and hyperlipidemia was associated with more guideline-concordant hypertension care, particularly if BP was far from goal. Efforts to understand and improve BP medication intensification in patients with controlled diabetes and/or hyperlipidemia are warranted. BioMed Central 2010-07-19 /pmc/articles/PMC2914084/ /pubmed/20642844 http://dx.doi.org/10.1186/1748-5908-5-55 Text en Copyright ©2010 Salanitro et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Salanitro, Amanda H
Funkhouser, Ellen
Agee, Bonita S
Allison, Jeroan J
Halanych, Jewell H
Houston, Thomas K
Litaker, Mark S
Levine, Deborah A
Safford, Monika M
Multiple uncontrolled conditions and blood pressure medication intensification: an observational study
title Multiple uncontrolled conditions and blood pressure medication intensification: an observational study
title_full Multiple uncontrolled conditions and blood pressure medication intensification: an observational study
title_fullStr Multiple uncontrolled conditions and blood pressure medication intensification: an observational study
title_full_unstemmed Multiple uncontrolled conditions and blood pressure medication intensification: an observational study
title_short Multiple uncontrolled conditions and blood pressure medication intensification: an observational study
title_sort multiple uncontrolled conditions and blood pressure medication intensification: an observational study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914084/
https://www.ncbi.nlm.nih.gov/pubmed/20642844
http://dx.doi.org/10.1186/1748-5908-5-55
work_keys_str_mv AT salanitroamandah multipleuncontrolledconditionsandbloodpressuremedicationintensificationanobservationalstudy
AT funkhouserellen multipleuncontrolledconditionsandbloodpressuremedicationintensificationanobservationalstudy
AT ageebonitas multipleuncontrolledconditionsandbloodpressuremedicationintensificationanobservationalstudy
AT allisonjeroanj multipleuncontrolledconditionsandbloodpressuremedicationintensificationanobservationalstudy
AT halanychjewellh multipleuncontrolledconditionsandbloodpressuremedicationintensificationanobservationalstudy
AT houstonthomask multipleuncontrolledconditionsandbloodpressuremedicationintensificationanobservationalstudy
AT litakermarks multipleuncontrolledconditionsandbloodpressuremedicationintensificationanobservationalstudy
AT levinedeboraha multipleuncontrolledconditionsandbloodpressuremedicationintensificationanobservationalstudy
AT saffordmonikam multipleuncontrolledconditionsandbloodpressuremedicationintensificationanobservationalstudy